GOOD NEWS! Phase I clinical trial results out of Johns Hopkins show a first-of-its-kind vaccine designed to target common KRAS mutations was safe AND stimulated KRAS-specific T-cell responses in 90% of study participants who were at HIGH risk of developing pancreatic ductal adenocarcinoma (PDAC).

Show Post

there weren't any good quality gifs of my melody taking it all off so now there are. here

Show Post

Gm everyone! Imma draw the Tsukino with Dr cat! Also wanna experiment with drawing more video game animals! #cat

Show Post

for dtiys

Show Post

Kapalı içerik

Show Post